中文名称: | Chk1-IN-5 | ||||
---|---|---|---|---|---|
英文名称: | Chk1-IN-5 | ||||
CAS No: | 2120398-39-0 | 分子式: | C18H18FN7O2 | 分子量: | 383.38 |
CAS No: | 2120398-39-0 | ||||
分子式: | C18H18FN7O2 | ||||
分子量: | 383.38 |
基本信息
产品编号: |
C10913 |
||||
产品名称: |
Chk1-IN-5 |
||||
CAS: |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
|
||||
分子式: |
溶于液体 |
-80℃ |
|
||
分子量 |
383.38 |
-20℃ |
|
||
化学名: |
|
生物活性
产品描述 |
一种有效的检查点激酶 1 (Chk1) 抑制剂。Chk1-IN-5 抑制 Chk1 磷酸化,并在结肠癌异种移植模型中抑制肿瘤生长。 |
|
靶点 |
Chk1 |
|
体外研究 |
Chk1-IN-5 (compound 3; 0.4, 1.2, 3.7, 11.1, 33.3, 100nM) inhibits Chk1 phosphorylation in the HT-29 colon cells |
|
体内研究 |
Chk1-IN-5 (compound 3; 40mg/kg; IV; twice a week for 21 days) inhibits tumor growth in Baib/c nude mice with HT-29 colon cancer cells Chk1-IN-5 (10mg/kg; via tail vein intravenous injection) displays a longer half-life (T1/2=3.8 hours) and higher exposure (CL=2.3 L/hr•kg; Vss=6.4 L/kg; AUC=4531 ng/ml•h) |
|
Animal Model: |
Baib/c nude mice with HT-29 colon cancer cells |
|
Dosage: |
40mg/kg |
|
Administration: |
IV; twice a week for 21 days |
|
Result: |
Inhibited tumor growth. |
|
|
|
|
Animal Model: |
Male SD rats (280-350 g) |
|
Dosage: |
10mg/kg |
|
Administration: |
Via tail vein intravenous injection |
|
Result: |
Displayed a longer half-life (T1/2=3.8 hours) and higher exposure (CL=2.3 L/hr•kg; Vss=6.4 L/kg; AUC=4531 ng/ml•h). |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )